This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Masarykova Univerzita. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Lumir Krejci: Innovator in Nuclease Inhibition
Introduction
Lumir Krejci is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit nucleases. With a total of three patents to his name, Krejci's work is focused on addressing critical health issues.
Latest Patents
Krejci's latest patents include "Substituted aminothiazoles as inhibitors of nucleases" and "Substituted propanamides as inhibitors of nucleases." Both patents describe compounds represented by specific structural formulas that serve as inhibitors of nucleases. These compounds are particularly useful in methods for treating and preventing proliferative diseases, neurodegenerative diseases, and other genomic instability-associated diseases.
Career Highlights
Krejci is affiliated with Masaryk University, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Krejci collaborates with esteemed colleagues, including Kamil Paruch and Benoit Carbain, to further enhance the scope and application of his research.
Conclusion
Lumir Krejci's innovative work in the development of nuclease inhibitors positions him as a key figure in biochemistry. His contributions have the potential to significantly impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile